SOPHROSYNE CAPITAL LLC Information

156 EAST 36TH STREET, NEW YORK, New York, 10016, (212) 444-2500

Report Date: 06/30/2014

Position Statistics

Total Positions 93
New Positions 14
Increased Positions 30
Decreased Positions 53
Positions with Activity 83
Sold Out Positions 29
Total Mkt Value (in $ millions) 98

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials 3.55%
Capital Goods 5.8%
Conglomerates 0%
Consumer Cyclical 0.13%
Consumer/Non-Cyclical 2.84%
Energy 0.4%
Financial 6.89%
Healthcare 39.04%
Services 4.92%
Technology 24.65%
Transportation 0.24%
Utilities 2.53%

93 Positions as of 06/30/2014

Company Class Value of Shares ($1,000s) ▲ Change in Value ($1,000s) Change (%) Shares Held
8X8 INC NEW COM -321 Sold Out 0
ACELRX PHARMACEUTICALS INC COM -1,688 Sold Out 0
ACORN ENERGY INC COM -636 Sold Out 0
ASTERIAS BIOTHERAPEUTICS INC COM SER A -15 Sold Out 0
CUTERA INC COM -1,368 Sold Out 0
DURATA THERAPEUTICS INC COM -1,690 Sold Out 0
EDWARDS LIFESCIENCES CORP COM -686 Sold Out 0
FIVE PRIME THERAPEUTICS INC COM -265 Sold Out 0
GERON CORP COM -340 Sold Out 0
HANGER INC COM NEW -542 Sold Out 0
INSPIREMD INC COM NEW -398 Sold Out 0
LINDSAY CORP COM -132 Sold Out 0
NATURAL GAS SERVICES GROUP COM -207 Sold Out 0
NEKTAR THERAPEUTICS COM -819 Sold Out 0
NET 1 UEPS TECHNOLOGIES INC COM NEW -4,254 Sold Out 0
OCULUS INNOVATIVE SCIENCES INC COM NEW -380 Sold Out 0
OMEGA PROTEIN CORP COM -50 Sold Out 0
PHARMATHENE INC COM -376 Sold Out 0
PICO HLDGS INC COM NEW -274 Sold Out 0
QUALYS INC COM -273 Sold Out 0